bromodeoxyuridine has been researched along with u 0126 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (65.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Beasley, D; Golenbock, DT; LaVerda, D; Qureshi, N; Sasu, S | 1 |
| Cox, ME; Deeble, PD; Murphy, DJ; Parsons, SJ | 1 |
| Dmitrieva, RI; Doris, PA | 1 |
| Arteaga, CL; Dumont, N; Koh, Y; Ueda, Y; Wang, S; Yi, JY | 1 |
| Feng, L; Hu, X; Jin, L | 1 |
| Cebrian, ME; Garrido, E; Ruiz-Ramos, R | 1 |
| Goldshmidt, A; Hamill, CE; Hepler, JR; Lyuboslavsky, P; McKeon, RJ; Nicole, O; Sastre, A; Sorensen, SD; Traynelis, SF | 1 |
| Cameron, RE; Dragunow, M; Gray, CW; Lim, J; Lind, CR; Narayan, PJ; O'Carroll, SJ; Pearson, AG | 1 |
| Dahlin, LB; Gustavsson, P; Kanje, M; Mårtensson, L | 1 |
| Amemori, S; Fujimoto, K; Fujise, T; Iwakiri, R; Kakimoto, T; Kuroki, T; Ootani, A; Sakata, Y; Shiraishi, R; Tsunada, S; Yokoyama, F | 1 |
| Dean, JL; Knudsen, ES; Mayhew, CN; Seeley, SL; Stengel, KR | 1 |
| Chen, T; Li, X; Mercaldo, V; Shang, Y; Wang, H; Zhuo, M | 1 |
| Bell, TJ; Oberholtzer, JC | 1 |
| Greig, NH; Holloway, HW; Li, Y; Mattson, MP; Tweedie, D | 1 |
| Di Lauro, M; Di Pascale, A; Grassia, G; Guglielmotti, A; Ialenti, A; Maddaluno, M; Santamaria, R | 1 |
| Du, H; Fang, M; Wu, D; Yao, W | 1 |
| Chen, Y; Fang, Z; Gao, F; Hou, W; Lao, N; Li, X; Nie, H; Peng, Z; Tan, Q; Wang, H; Xiong, L | 1 |
| Chen, GS; Hou, PS; Huang, SM; Lai, HC; Lan, CE; Peng, YT; Wu, CH; Wu, CS; Yang, HJ | 1 |
| Anderson, B; Drinkwater, K; Hampel, D; Mody, A; Seangmany, N; Shim, M | 1 |
20 other study(ies) available for bromodeoxyuridine and u 0126
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation.
Topics: Bacterial Proteins; Bromodeoxyuridine; Butadienes; Cell Division; Cells, Cultured; Chaperonin 60; Chlamydophila Infections; Chlamydophila pneumoniae; Drosophila Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Hot Temperature; Humans; Lipid A; Membrane Glycoproteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Nitriles; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saphenous Vein; Toll-Like Receptor 4; Toll-Like Receptors | 2001 |
Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
Topics: Bromodeoxyuridine; Butadienes; Cell Differentiation; Cell Division; Chloramphenicol O-Acetyltransferase; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epinephrine; Humans; Immunoblotting; Immunoenzyme Techniques; Interleukin-6; Male; MAP Kinase Signaling System; Mitosis; Nitriles; Phenotype; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Ribonucleases; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
Ouabain is a potent promoter of growth and activator of ERK1/2 in ouabain-resistant rat renal epithelial cells.
Topics: Animals; Biological Transport; Blotting, Western; Bromodeoxyuridine; Butadienes; Cell Division; Cells, Cultured; Coloring Agents; DNA; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Activation; Enzyme Inhibitors; Epithelial Cells; Histones; Inhibitory Concentration 50; Ions; Kidney; Male; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; Ouabain; Phosphorylation; Protein Isoforms; Rats; Regression Analysis; Signal Transduction; Sodium; Sodium-Potassium-Exchanging ATPase; Tetrazolium Salts; Thiazoles; Time Factors | 2003 |
Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
Topics: Actins; Activin Receptors, Type I; Adenoviridae; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Blotting, Northern; Breast Neoplasms; Bromodeoxyuridine; Butadienes; Cell Cycle; Cell Division; Cell Line; Cell Line, Tumor; Cell Movement; Chromones; Disease Progression; DNA, Complementary; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Genes, Reporter; Green Fluorescent Proteins; Humans; Imidazoles; Immunoblotting; Integrin beta1; Ligands; Luminescent Proteins; Microscopy, Fluorescence; Models, Genetic; Morpholines; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Precipitin Tests; Protein Serine-Threonine Kinases; Pseudopodia; Pyridines; rac1 GTP-Binding Protein; Receptor, ErbB-2; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Retroviridae; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta; Trastuzumab; Wound Healing | 2004 |
Erk1/2 but not PI3K pathway is required for neurotrophin 3-induced oligodendrocyte differentiation of post-natal neural stem cells.
Topics: Animals; Animals, Newborn; Basic Helix-Loop-Helix Transcription Factors; Blotting, Western; Bromodeoxyuridine; Butadienes; Cell Count; Cell Differentiation; Cells, Cultured; Chromones; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Indoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Models, Neurological; Morpholines; Nerve Tissue Proteins; Neurons; Neurotrophin 3; Nitriles; Oligodendroglia; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Transcription Factors; Tubulin | 2004 |
Benzoquinone activates the ERK/MAPK signaling pathway via ROS production in HL-60 cells.
Topics: Benzoquinones; Bromodeoxyuridine; Butadienes; Catalase; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Flavonoids; HL-60 Cells; Humans; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Reactive Oxygen Species; Signal Transduction | 2005 |
Activation of protease-activated receptor-1 triggers astrogliosis after brain injury.
Topics: Amides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Blotting, Northern; Blotting, Western; Brain Injuries; Bromodeoxyuridine; Butadienes; Cell Count; Cell Movement; Cell Proliferation; Cells, Cultured; Coculture Techniques; Colforsin; Cyclin D1; Disease Models, Animal; Drug Interactions; Enzyme Inhibitors; Functional Laterality; Glial Fibrillary Acidic Protein; Gliosis; Immunohistochemistry; Male; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Microglia; Nitriles; Oligopeptides; Pyridines; Receptor, PAR-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thrombin; Time Factors | 2005 |
The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells.
Topics: Analysis of Variance; Animals; Blotting, Western; Bromodeoxyuridine; Butadienes; Caspase 3; Cell Count; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression; Glial Fibrillary Acidic Protein; Glioma; Immunohistochemistry; Mice; Nitriles; Tetrazolium Salts; Thiazoles | 2006 |
Activation of extracellular-signal-regulated kinase-1/2 precedes and is required for injury-induced Schwann cell proliferation.
Topics: Analysis of Variance; Animals; Axotomy; Bromodeoxyuridine; Butadienes; Cell Count; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Male; Mitogen-Activated Protein Kinase 3; Nitriles; Organ Culture Techniques; Phosphorylation; Rats; Rats, Sprague-Dawley; Schwann Cells; Sciatic Neuropathy; Time Factors | 2007 |
Differentiation of gastric surface mucous cells (GSM06) induced by air-liquid interface is regulated partly through mitogen-activated protein kinase pathway.
Topics: Animals; Bromodeoxyuridine; Butadienes; Cell Differentiation; Cell Line; Enzyme Activation; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Gastric Mucosa; MAP Kinase Signaling System; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Nitriles; Phosphorylation | 2007 |
RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Butadienes; Cell Line, Transformed; Chromones; DNA Primers; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Fibroblasts; Flow Cytometry; Immunoblotting; MAP Kinase Kinase Kinases; Mice; Morpholines; Nitriles; Phosphatidylinositol 3-Kinases; Polymerase Chain Reaction; Retinoblastoma Protein; Signal Transduction | 2008 |
Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice.
Topics: 2-Amino-5-phosphonovalerate; Alanine; Analysis of Variance; Animals; Biophysics; Bromodeoxyuridine; Butadienes; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fragile X Mental Retardation Protein; GABA Antagonists; Gene Expression Regulation; Glycine; Glycine Agents; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase Kinases; Nitriles; Patch-Clamp Techniques; Picrotoxin; Pyramidal Cells | 2009 |
cAMP-induced auditory supporting cell proliferation is mediated by ERK MAPK signaling pathway.
Topics: Animals; Antimetabolites; Apigenin; Birds; Bromodeoxyuridine; Butadienes; Cell Division; Colforsin; Cyclic AMP; Enzyme Inhibitors; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hair Cells, Auditory; Macrolides; MAP Kinase Signaling System; Myosin VIIa; Myosins; Nitriles; Organ Culture Techniques; Organ of Corti; Proto-Oncogene Proteins B-raf | 2010 |
Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Topics: Activating Transcription Factor 4; Adrenergic Agents; Apoptosis; bcl-2-Associated X Protein; Bromodeoxyuridine; Butadienes; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Neuroblastoma; Neuroprotective Agents; Nitriles; Oxidants; Oxidopamine; Peptides; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucagon; Signal Transduction; Time Factors; Transfection; Venoms | 2010 |
Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation.
Topics: Bromodeoxyuridine; Butadienes; Cell Proliferation; Chemokine CCL7; Chromones; Coronary Vessels; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Morpholines; Myocardium; Myocytes, Smooth Muscle; NF-kappa B; Nitriles; Receptors, CCR2; Time Factors | 2011 |
ARF triggers cell G1 arrest by a P53 independent ERK pathway.
Topics: Bromodeoxyuridine; Butadienes; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation; HCT116 Cells; HEK293 Cells; Humans; MAP Kinase Signaling System; Nitriles; Phosphorylation; rho GTP-Binding Proteins; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2011 |
Rosmarinic acid ameliorates PTSD-like symptoms in a rat model and promotes cell proliferation in the hippocampus.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bromodeoxyuridine; Butadienes; Cell Proliferation; Cell Survival; Cells, Cultured; Cinnamates; Depsides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Freezing Reaction, Cataleptic; Hippocampus; Male; MAP Kinase Signaling System; Maze Learning; Motor Activity; Neural Stem Cells; Nitriles; Rats; Rats, Sprague-Dawley; Rosmarinic Acid; Stress Disorders, Post-Traumatic | 2014 |
Irradiance-dependent UVB Photocarcinogenesis.
Topics: Adult; Animals; Bromodeoxyuridine; Butadienes; Carcinogenesis; Cell Count; Cell Survival; Cells, Cultured; Dermatitis, Contact; DNA Damage; Extracellular Signal-Regulated MAP Kinases; G2 Phase; Humans; Immunosuppression Therapy; Keratinocytes; Mice, Hairless; Mitosis; Mutation; Nitriles; Protein Kinase Inhibitors; Pyrimidine Dimers; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays | 2016 |
Interleukin-11 (IL11) inhibits myogenic differentiation of C2C12 cells through activation of extracellular signal-regulated kinase (ERK).
Topics: Animals; Bromodeoxyuridine; Cachexia; Cell Differentiation; Extracellular Signal-Regulated MAP Kinases; Interleukin-11; Mice; Muscle Development; Myoblasts; Myogenin; Myosin Heavy Chains; Neoplasms | 2023 |